Originating from Y Combinator (S17), our team of engineers, scientists and industry experts are redefining healthcare with tools that quantify biology.
Oguzhan believes that diagnostics can be made much more powerful, accurate, and affordable if they were engineered to be quantitative. At BillionToOne, Oguzhan helped develop a patent-pending molecular counter platform that increases the resolution of molecular diagnostics by over a thousandfold. He has led BillionToOne through Y Combinator and raised a total of 17.5M in funding including from venture capital funds and investors who previously invested in tech companies such as SpaceX, Box, Spotify, Palantir, Braintree, and biotech companies such as Counsyl, WebMD, and Omada Health. Oguzhan received his PhD from Stanford, where his work was published on the Cover of Cell Systems.
Previously, Oguzhan graduated
David believes that applying engineering principles to biology will be transformative for medicine. He is the original inventor of the DNA molecular counting platform at BillionToOne and has presented BillionToOne’s clinical trial results at national medical conferences. David has a bachelor’s degree in Physics, cum laude, from Princeton University with minors in Biophysics and Engineering Management Systems. While at Princeton, he was twice awarded the Shenstone Prize in Physics. He received a PhD in bioengineering from Rice University, where he was awarded a Nanobiology training fellowship.
Nipun Soni joined as our Chief Financial Officer in March 2021 and brings 20 years of finance, accounting and operations experience with multi-national companies in the Healthcare and Technology sector. Prior to joining BillionToOne, he served as SVP Finance at Guardant Health from July 2019 to March 2021, helping scale the finance organization for a growing public company. Between April 2009 to July 2019, he held various senior finance leadership positions with multi-national public companies including Quotient Technology, KLA Corporation and Oracle Corporation. Earlier in his career, he worked at PricewaterhouseCoopers serving clients in both public and private sectors. He holds a Bachelor’s in Commerce from Delhi University, India and is a CFA Charterholder, Certified Public Accountant licensed in California and Chartered Accountant from India.
He is passionate about building high-performing teams as well as using automation to drive scale and continuous improvement in finance operations for high-growth companies.
Nancy has a passion for building and leading commercial sales teams. She believes in the empowerment of individuals to achieve personal and professional goals. Nancy brings more than 20 years of diagnostic sales leadership experience in both start-up and large-scale sales organizations. Nancy joins BillionToOne from Foundation Medicine where she played an instrumental role in the company’s commercial strategy and execution, building and leading her sales team to success. Prior to Foundation Medicine Nancy held several commercial leadership positions at various molecular diagnostic companies. Nancy started her career as a board-certified Medical Technologist and holds a BS in Medical Technology from Creighton University
Shan is passionate about launching life-changing products and delivering seamless end-to-end user experience through the products. Shan has 10+ years of experience in launching wide range of products and brands, from online marketplace to cord blood banking and is responsible for all aspects of product at BillionToOne. Shan started her career at McKinsey & Co., where she helped launch two pharmaceutical drugs and a new brand line of high-end audio products for multinational corporations. Shan holds MBA from Stanford University, MPA/ID from Harvard University, and BS in Chemistry and Minor in Biology from Massachusetts Institute of Technology (Phi Beta Kappa).
John has a passion for genomics, laboratory medicine, and providing quality care to the patients he serves. John has over 10 years of experience providing leadership to high complexity CLIA laboratories including regulatory oversight, clinical laboratory operations, and test development. He joins BillionToOne from Kaiser Permanente where he served both as Laboratory Director and Director of Quality in the Molecular Pathology and Cytogenetics laboratories. John received his PhD in Molecular and Cell Biology from UC Berkeley and served as a Postdoctoral Fellow in Laboratory Genetics and Genomics at Stanford and UCLA.
As a certified genetic counselor with over 17 years of clinical experience, Jen is committed to ensuring patients and providers are supported and educated about the options and utility of prenatal testing. Jen joins BillionToOne after 17 years as a prenatal genetic counselor at UTHealth where she led a team of genetic counselors providing patient care in MFM clinics across the city of Houston. Jen has extensive volunteer and leadership experience within national societies such as American College of Obstetrics and Gynecology and National Society of Genetic Counselors and served as president of NSGC in 2014. Jen earned her MS in genetic counseling from the University of Texas Health Science Center in Houston and received her BS in Biology with a minor in Chemistry from Truman State University.
Brent believes that one size does not fit all with hospitals, physicians, and patients. Brent drives our sales strategy and operations teams to ensure customer loyalty while improving the satisfaction of both internal and external partners. An unrelenting executionist, Brent has fiercely loyal customers and has helped multiple startups with hyper-growth plans from series A through IPO. Brent graduated from Arizona and has a history of success in the tech and biotech industry.
Brian believes that biomolecules are the engineering tools of the future. Brian has published eight peer reviewed publications in top tier journals and written three patents. Brian was a National Defense Science and Engineering fellow and co-wrote grants that secured over one million dollars in funding during his graduate work. Brian holds a PhD in Bioengineering from Rice University and a BS in Biomedical Engineering from Washington University in St. Louis.
With over 23 years in the healthcare industry, David is an innovative and strategic business executive with experience leading market access strategy, reimbursement, and managed care initiatives to drive growth.
David is recognized for securing coverage and target reimbursement for new technology and focus tests. He is a trusted advisor to key stakeholders, senior management, and cross-functional teams in evaluating new opportunities.
David identifies and develops system efficiencies and automation while hiring, engaging, and retaining top talent to achieve business goals through coaching, collaboration, and mentoring.
Kitty is a passionate, interdisciplinary diagnostic scientist with experience in R&D and in clinical operations. She began as a R&D chemist at Inova Diagnostics, where she was the primary developer of QUANTA Flash DGP Screen, which received FDA 510k approval. Her experience as a Clinical Laboratory Scientist spans from NIPT at Sequenom, pharmacogenetics at Millennium Health, and cancer diagnostics at Guardant Health. Kitty received her BA in Molecular and Cell Biology from UC Berkeley and clinical training from UC Irvine.
Devon is passionate about engineering biological systems which he thinks can be leveraged to solve challenges in medicine and improve people’s lives. He earned his PhD in Biology at Stanford University where he authored several peer-reviewed publications and was awarded a Genentech Foundation Predoctoral Fellowship. Previously, Devon graduated with a BS in Biochemistry and Biology from University of Washington.
Anna is responsible for BTO’s quality and regulatory efforts, ensuring approval and maintenance of licenses needed to operate as a diagnostics company. Anna was a Lab Scientist in Transfusion Medicine and Cellular Therapies for top academic hospitals including Medical University of South Carolina, Tufts Medical Center, Dana-Farber/Harvard Cancer Center, and UCSF. Prior to joining, Anna was a Regulatory Consultant at FibroGen supporting IND and NDA activities on the anemia drug, Roxadustat. Anna holds a BS in Medical Technology from the University of Santo Tomas and an MS in Regulatory Affairs for Drugs, Biologics, and Medical Devices from Northeastern University.
Sharon believes in helping patients make the right decisions about their health with her work as a Clinical Lab Scientist. Sharon has over 10 years of experience in both the hospital setting and biotech industry having worked at Stanford University Medical Center, Kaiser Permanente, Genomic Health and Guardant Health. Prior to joining BillionToOne, Sharon was the Clinical Operations Supervisor at Guardant Health who helped build the Clinical Lab and grow the Operations team from a staff of 10 to over 60 team members. Sharon holds a BS in Biological Sciences from California State University-East Bay and graduated from the Clinical Laboratory Science Program at San Jose State University.
Patrick knows that molecular biology can be harnessed to overcome previously unsolved challenges in molecular diagnostics to impact people’s lives. Patrick earned his PhD in Bioengineering from Stanford University, during which he authored several peer-reviewed publications. A truly interdisciplinary scientist and engineering, Patrick received a Stanford Interdisciplinary Graduate Fellowship and was named a Siebel Scholar.
We believe what we do should count.
It should make an impact.
It should change lives.